Citadel Advisors »

Acelrx Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Acelrx Pharmaceuticals (TLPH) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Acelrx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Acelrx Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acelrx Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $22k 30k 0.74

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Acelrx Pharmaceuticals

Nantahala Capital Management
Rosalind Advisors
Cantor Fitzgerald, L. P.
Tang Capital Management
Vanguard Group
Values First Advisors
Turtle Creek Wealth Advisors
Virtu Financial
Citadel Advisors
Millennium Management
Jane Street
UBS Group
Advisor Group Holdings
Wells Fargo & Company
Advisory Services Network

View all funds holding Acelrx Pharmaceuticals